Recombinant HCV E2 Glycoprotein for use in HCV Vaccine Treatment

Details for Australian Patent Application No. 2006906282 (hide)

Owner The Macfarlane Burnet Institute for Medical Research and Public Health Ltd.

Agent Davies Collison Cave

Filing date 10 November 2006

Event Publications

23 November 2006 Provisional Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006906283-Marking device

2006906281-Food Probe